Abstract
A large proportion of adult patients with acute myeloid leukemia (AML) relapse after treatment, and some of them are resistant to primary induction chemotherapy. Sixty-one patients from seven hematological centers with poor-risk AML, primary refractory (n = 16), or relapsed (n = 45) were treated with a salvage regimen, including fludarabine (2 days) and cytarabine (3 days) in a sequential continuous infusion, associated with liposomal daunorubicin (3 days) (FLAD). Complete response rate was 44% and 56% for refractory and relapsed patients, respectively, with an overall response rate of 52% (32 of 61). Twenty-two patients (36%) were resistant to the salvage therapy. Seven patients (12%) died early during chemotherapy, four of them because of sepsis. Nineteen patients in complete remission (CR) underwent a stem-cell transplant (SCT) procedure: five autologous, nine from a HL-A identical sibling, and five from HL-A matched unrelated donors. Post-treatment aplasia and mucositis were major toxicities. Twenty patients (62.5%) relapsed after this treatment in a median of 7.3 months; ten patients relapsed after a SCT procedure. Nine patients are alive and disease free; three of them were rescued after a further cytotoxic treatment. The...Continue Reading
References
Sep 12, 1987·Lancet·R A SellsI T Gilmore
Dec 1, 1987·Cancer Treatment Reviews·R A SellsR E Stringer
Oct 1, 1985·Annals of Internal Medicine·J M BennettC Sultan
Jan 1, 1985·Clinical and Laboratory Haematology·A ShibataL T Yam
Apr 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P S GillA M Levine
Jan 26, 1995·The New England Journal of Medicine·R A ZittounG Papa
Jan 1, 1994·Investigational New Drugs·P GuaglianoneF Muggia
Jan 1, 1993·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·V GandhiW Plunkett
Jul 1, 1996·Leukemia & Lymphoma·M ClavioM Gobbi
Jun 13, 1998·American Journal of Hematology·M MontilloF Ferrara
Sep 30, 1998·British Journal of Haematology·S KeatingR A Zittoun
Jun 22, 1999·Leukemia·J L ByrneN H Russell
Aug 12, 1999·British Journal of Haematology·M MichieliM Baccarani
Nov 11, 1999·Investigational New Drugs·J CortesH Kantarjian
Nov 26, 1999·Cancer·F FerraraM Montillo
Mar 17, 2000·Leukemia·E H Estey
Feb 13, 2001·British Journal of Haematology·G JacksonM P Wilson
May 23, 2001·Blood·M M van den Heuvel-EibrinkP Sonneveld
May 30, 2001·Leukemia & Lymphoma·B VidarssonW L Longo
Jun 28, 2001·Leukemia & Lymphoma·A M CarellaM Carotenuto
Feb 14, 2002·British Journal of Haematology·A FassasP Kaloyannidis
Jul 26, 2002·British Journal of Haematology·Alan K BurnettUNKNOWN Medical Research Council Adult and Paediatric Working Parties
Sep 20, 2002·Blood·James W VardimanRichard D Brunning
Apr 9, 2004·Blood·Gert J OssenkoppeleUNKNOWN Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON)
Aug 24, 2004·Annals of Hematology·Marino ClavioMarco Gobbi
Jul 16, 2005·Leukemia & Lymphoma·Athanasios Fassas, Achilles Anagnostopoulos
Citations
Jul 26, 2012·Blood Cancer Journal·M NiapourS A Berger
Mar 15, 2011·Immunotherapy·Francois Fay, Christopher J Scott
Jan 19, 2011·Haematologica·Katharina WagnerJürgen Krauter
Jul 2, 2011·Haematologica·Lars MöllgårdEva Hellström-Lindberg
Jan 25, 2013·Therapeutic Delivery·Seth M Miller, Andrew Z Wang
Oct 26, 2013·Paediatric Drugs·Jennifer DavilaThomas Renaud
Jan 6, 2010·Journal of Oncology·Biljana Culjkovic, Katherine L Borden
Jul 6, 2014·Annals of Hematology·Enrico De AstisMarco Gobbi
Dec 15, 2010·Journal of Cancer Research and Clinical Oncology·Liu-Fang GuXiao-Rong Ma
Jan 28, 2012·Leukemia & Lymphoma·Eunice S WangWendy Stock
Sep 25, 2015·Expert Review of Anticancer Therapy·Edouard AlphandéryMickael Durand-Dubief
Jan 30, 2010·Clinical Therapeutics·Tadeusz Robak, Agnieszka Wierzbowska
Mar 30, 2013·Leukemia Research·Xi ZhangLei Gao
Feb 1, 2017·Leukemia·M WattadR F Schlenk
Jan 24, 2019·Expert Review of Clinical Pharmacology·Juan Eduardo Megías-VericatPau Montesinos
Jan 7, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Weiwei GaoLiangfang Zhang
Mar 8, 2012·Journal of Pediatric Hematology/oncology·Paola QuarelloFranca Fagioli
Apr 24, 2018·Annals of Hematology·Juan Eduardo Megías-VericatPau Montesinos
Sep 16, 2020·Blood·Geoffrey L UyJohn F DiPersio